Evidence map›Paper›PMID 35252965›Full record

ArticleImmuno2022

Autophagy in Virus Infection: A Race between Host Immune Response and Viral Antagonism.

Karan Chawla, Gayatri Subramanian, Tia Rahman, Shumin Fan, Sukanya Chakravarty, Shreyas Gujja, Hayley Demchak, Ritu Chakravarti, Saurabh Chattopadhyay

Abstract read
In one paragraph

Article in Immuno, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Autophagy and SARS-CoV-2-Old Players in New Games.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karan ChawlaDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.ORCID 0000-0002-2427-9654
Gayatri SubramanianDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Tia RahmanDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Shumin FanDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Sukanya ChakravartyDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Shreyas GujjaDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Hayley DemchakDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Ritu ChakravartiDepartment of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Saurabh ChattopadhyayDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.ORCID 0000-0002-2930-1523

Funding

Transcriptional and non-transcriptional functions of IRF3 in ALDR01AA027456 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI LAURA E. NAGY · 2019 to 2026
$3.5M
Anti-inflammatory functions for non-transcriptional IRF3R01AI155545 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI Saurabh Chattopadhyay · 2021 to 2026
$2.2M
Understanding the proviral role for TRAF6 interaction with the viral protease in flavivirus replication and pathogenesisR01AI153496 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI TAYLOR, ROGER TRAVIS · 2020 to 2024
$1.9M
Novel antiviral mechanisms of the interferon systemR01AI165521 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI Saurabh Chattopadhyay · 2022 to 2026
$1.7M
How Non-transcriptional IRF3 Prevents ALDR21AA026017 · NIAAA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI CHATTOPADHYAY, SAURABH · 2018 to 2019
$403k
NIAAA NIH HHS R01 AA027456NIAAA NIH HHS R21 AA026017NIAID NIH HHS R01 AI153496NIAID NIH HHS R01 AI155545NIAID NIH HHS R01 AI165521
6 · The paper itself

Abstract

Virus-infected cells trigger a robust innate immune response and facilitate virus replication. Here, we review the role of autophagy in virus infection, focusing on both pro-viral and anti-viral host responses using a select group of viruses. Autophagy is a cellular degradation pathway operated at the basal level to maintain homeostasis and is induced by external stimuli for specific functions. The degradative function of autophagy is considered a cellular anti-viral immune response. However, autophagy is a double-edged sword in viral infection; viruses often benefit from it, and the infected cells can also use it to inhibit viral replication. In addition to viral regulation, autophagy pathway proteins also function in autophagy-independent manners to regulate immune responses. Since viruses have co-evolved with hosts, they have developed ways to evade the anti-viral autophagic responses of the cells. Some of these mechanisms are also covered in our review. Lastly, we conclude with the thought that autophagy can be targeted for therapeutic interventions against viral diseases.

Indexed as

anti-viral responseautophagyinnate immunitypro-viral responseviral antagonism

Identifiers

PMID35252965
PMCPMC8893043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.